Novavax, Inc. announced a private placement to issue 6,500,000 common shares at an issue price of $13 per share for the gross proceeds of $84,500,000 on August 8, 2023. The transaction will include participation from new investor SK bioscience Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57,900 KRW | -2.85% | -3.18% | -19.58% |
May. 03 | SK Bioscience's Attributable Loss Narrows in Q1 | MT |
Mar. 28 | SK Bioscience Signs Deal with Sanofi for Five Vaccine Types | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
57,900 KRW | -2.85% | -3.18% | 3.37B | ||
14.46 USD | -2.27% | +6.68% | 2.08B | ||
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.58% | 3.37B | |
-3.15% | 89.69B | |
+2.50% | 41.34B | |
-12.39% | 33.72B | |
+62.74% | 26.11B | |
-20.70% | 14.63B | |
-9.11% | 12.84B | |
-12.34% | 11.66B | |
-43.92% | 11.52B | |
+4.27% | 8.92B |
- Stock Market
- Equities
- A302440 Stock
- News SK bioscience Co.,Ltd.
- Novavax, Inc. announced that it expects to receive $84.5 million in funding from SK bioscience Co.,Ltd.